Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses

被引:94
作者
Gauvreau, Gail M.
Hessel, Edith M.
Boulet, Louis-Philippe
Coffman, Robert L.
O'Byrne, Paul M.
机构
[1] McMaster Univ, Hamilton, ON L8N 3Z5, Canada
[2] Hop Laval, Quebec City, PQ, Canada
[3] Dynavax Technol, Berkeley, CA USA
关键词
airway responses; allergen inhalation challenge; allergic asthma; gene expression; immunostimulatory CpG motifs;
D O I
10.1164/rccm.200601-057OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: 1018 ISS is a synthetic oligonucleotide containing immunostimulatory CpG motifs. In animal studies, 1018 ISS effectively inhibited Th2-mediated lung inflammation, including eosinophil infiltration, and airway hyperresponsiveness. Objectives: To evaluate whether 1018 ISS has activity in subjects with allergic asthma. Methods: Forty subjects (n = 21, 1018 ISS; In = 19, placebo) were enrolled in a randomized, double-blind, placebo-controlled, parallel-group study to examine safety, pharmacologic activity, and efficacy of 1018 ISS on allergen-induced airway responses. Subjects received 36 mg of 1018 ISS or placebo by nebulization weekly for 4 wk. Measurements: Allergen inhalation challenge was performed 24 h after the 2nd and 4th doses to measure the early and late fall in FEV1. Sputum cells and peripheral blood mononuclear cells were collected before and after dosing, and gene expression was measured by quantitative polymerase chain reaction. Main Results: Treatment with 1018 ISS significantly increased expression of interferon (IFN)-gamma and IFN-inclucible genes, such as IFN-gamma-inducible 10 kD protein (IP10), monokine induced by IFN-gamma (MIG), IFN-stimulated gene (ISG)-54, monocyte chemotactic protein (MCP)-1, and MCP-2 from cells collected postdose (p < 0.05). There was no attenuation of the early or late decrease in FEV1 after 1018 ISS compared with placebo, nor a reduction in allergen-induced sputum eosinophils or Th2-related gene expression measured in sputum cells. Conclusions: This study demonstrated that 1018ISS is safe and pharmacologically active in the respiratory tract of asthmatics but, at this dose regimen, did not inhibit a fall in FEV1 or other key features of the response to inhaled allergen challenge. This suggests that induction of IFN and IFN-inclucible genes alone is not sufficient to inhibit allergen-induced responses in asthmatic subjects.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 41 条
[1]   Effect of a single dose of the selectin inhibitor TBC1269 on early and late asthmatic responses [J].
Avila, PC ;
Boushey, HA ;
Wong, H ;
Grundland, H ;
Liu, J ;
Fahy, JV .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (01) :77-84
[2]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[3]  
Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO
[4]  
2-R
[5]  
Broide D, 1998, J IMMUNOL, V161, P7054
[6]   Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma [J].
Broide, DH ;
Stachnick, G ;
Castaneda, D ;
Nayar, J ;
Miller, M ;
Cho, JY ;
Roman, M ;
Zubeldia, J ;
Hyashi, T ;
Raz, E .
JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (03) :175-182
[7]  
COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264
[8]  
Cockcroft DW, 1985, MEASURE AIRWAY RESPO, P22
[9]   The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects [J].
Fahy, JV ;
Fleming, HE ;
Wong, HH ;
Liu, JT ;
Su, JQ ;
Reimann, J ;
Fick, RB ;
Boushey, HA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) :1828-1834
[10]   CELLULAR AND BIOCHEMICAL-ANALYSIS OF INDUCED SPUTUM FROM ASTHMATIC AND FROM HEALTHY-SUBJECTS [J].
FAHY, JV ;
LIU, J ;
WONG, H ;
BOUSHEY, HA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (05) :1126-1131